Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 8/20 | 0.35 |
| ▸ | CALML3 | P27482 | 5/20 | 0.35 |
| ▸ | MAOB | P27338 | 6/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | SDHA | P31040 | 1/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7459673 | 0.84 | MAOA (0.35) | MAOACALML3MAOBCYP2C19CYP2C9 | |
| Posizolid SCHEMBL374786 | 0.80 | MAOA (0.34) | MAOACALML3MAOBCYP2C19CYP2C9 | |
| Posizolid SCHEMBL14286008 | 0.80 | MAOA (0.34) | MAOACALML3MAOBCYP2C19CYP2C9 | |
| Posizolid SCHEMBL7079325 | 0.80 | MAOA (0.34) | MAOACALML3MAOBCYP2C19CYP2C9 | |
| Posizolid SCHEMBL3039615 | 0.80 | MAOA (0.34) | MAOACALML3MAOBCYP2C19CYP2C9 | |
| SCHEMBL12674052 | 0.79 | GRM2 (0.37) | MAOACALML3GRM2 | |
| SCHEMBL5229382 | 0.79 | GRM2 (0.37) | MAOACALML3GRM2 | |
| Hydrochloric Acid SCHEMBL7081708 | 0.78 | GRM2 (0.37) | MAOACALML3GRM2 | |
| Hydrochloric Acid SCHEMBL7081703 | 0.78 | GRM2 (0.37) | MAOACALML3GRM2 | |
| SCHEMBL7134192 | 0.77 | MAOB (0.48) | MAOACALML3MAOBLMNAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2408452-A1 | COMPOUND FOR THE TREATMENT OF TUBERCULOSIS | AstraZeneca AB (SE) | 2012-01-25 | — | — | EP | claimed |
| WO-2010106355-A1 | COMPOUND FOR THE TREATMENT OF TUBERCULOSIS | ASTRAZENECA AB (SE) | 2010-09-23 | — | — | WO | claimed |
| EP-2408452-A1 | COMPOUND FOR THE TREATMENT OF TUBERCULOSIS | AstraZeneca AB (SE) | 2012-01-25 | — | — | EP | disclosed |
| WO-2010106355-A1 | COMPOUND FOR THE TREATMENT OF TUBERCULOSIS | ASTRAZENECA AB (SE) | 2010-09-23 | — | — | WO | disclosed |